Cargando…

The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study

AIM OF THE STUDY: Hepatocellular carcinoma (HCC) prognosis heavily depends on early diagnosis. We aimed to determine the role of serum urothelial carcinoma-associated 1 (UCA1) and wd repeat containing antisense to TP53 (WRAP53) as diagnostic tools of HCC. MATERIAL AND METHODS: A case-control study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelmoety, Amr Aly, Elhassafy, Mohamed Youssef, Said, Rasha Said Omar, Elsheaita, Ahmed, Mahmoud, Manal Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369654/
https://www.ncbi.nlm.nih.gov/pubmed/37502440
http://dx.doi.org/10.5114/ceh.2023.127569
_version_ 1785077803913314304
author Abdelmoety, Amr Aly
Elhassafy, Mohamed Youssef
Said, Rasha Said Omar
Elsheaita, Ahmed
Mahmoud, Manal Mohamed
author_facet Abdelmoety, Amr Aly
Elhassafy, Mohamed Youssef
Said, Rasha Said Omar
Elsheaita, Ahmed
Mahmoud, Manal Mohamed
author_sort Abdelmoety, Amr Aly
collection PubMed
description AIM OF THE STUDY: Hepatocellular carcinoma (HCC) prognosis heavily depends on early diagnosis. We aimed to determine the role of serum urothelial carcinoma-associated 1 (UCA1) and wd repeat containing antisense to TP53 (WRAP53) as diagnostic tools of HCC. MATERIAL AND METHODS: A case-control study including 90 subjects (30 patients having HCC, 30 patients having liver cirrhosis without HCC and 30 healthy controls) was performed. In all participants, the serum levels of UCA1 and WRAP53 were assessed by quantitative real-time polymerase chain reaction together with serumαa-fetoprotein (AFP). RESULTS: Serum levels of both UCA1 and WRAP53 were upregulated in patients with HCC being significantly higher than in patients with liver cirrhosis and healthy control (p < 0.001). They were also correlated with some clinicopathological characteristics of HCC. Using the receiver operating curve, both UCA1 and WRAP53 showed higher diagnostic performance for HCC (AUC = 0.9, 73.3% sensitivity, 100% specificity and AUC = 0.85, 63.3% sensitivity, 80% specificity respectively) and their combination with AFP resulted in improved sensitivity and specificity (AUC = 0.97, 90% sensitivity, 100% specificity). CONCLUSIONS: Serum UCA1 and WRAP53 have the potential to be used alone, or in combination or with AFP, as diagnostic non-invasive biomarkers for HCC with accepted sensitivity and specificity. This study has been registered in clinicaltrials.gov with clinical trial registration number NCT05088811.
format Online
Article
Text
id pubmed-10369654
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-103696542023-07-27 The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study Abdelmoety, Amr Aly Elhassafy, Mohamed Youssef Said, Rasha Said Omar Elsheaita, Ahmed Mahmoud, Manal Mohamed Clin Exp Hepatol Original Paper AIM OF THE STUDY: Hepatocellular carcinoma (HCC) prognosis heavily depends on early diagnosis. We aimed to determine the role of serum urothelial carcinoma-associated 1 (UCA1) and wd repeat containing antisense to TP53 (WRAP53) as diagnostic tools of HCC. MATERIAL AND METHODS: A case-control study including 90 subjects (30 patients having HCC, 30 patients having liver cirrhosis without HCC and 30 healthy controls) was performed. In all participants, the serum levels of UCA1 and WRAP53 were assessed by quantitative real-time polymerase chain reaction together with serumαa-fetoprotein (AFP). RESULTS: Serum levels of both UCA1 and WRAP53 were upregulated in patients with HCC being significantly higher than in patients with liver cirrhosis and healthy control (p < 0.001). They were also correlated with some clinicopathological characteristics of HCC. Using the receiver operating curve, both UCA1 and WRAP53 showed higher diagnostic performance for HCC (AUC = 0.9, 73.3% sensitivity, 100% specificity and AUC = 0.85, 63.3% sensitivity, 80% specificity respectively) and their combination with AFP resulted in improved sensitivity and specificity (AUC = 0.97, 90% sensitivity, 100% specificity). CONCLUSIONS: Serum UCA1 and WRAP53 have the potential to be used alone, or in combination or with AFP, as diagnostic non-invasive biomarkers for HCC with accepted sensitivity and specificity. This study has been registered in clinicaltrials.gov with clinical trial registration number NCT05088811. Termedia Publishing House 2023-06-18 2023-06 /pmc/articles/PMC10369654/ /pubmed/37502440 http://dx.doi.org/10.5114/ceh.2023.127569 Text en Copyright © 2023 Clinical and Experimental Hepatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Original Paper
Abdelmoety, Amr Aly
Elhassafy, Mohamed Youssef
Said, Rasha Said Omar
Elsheaita, Ahmed
Mahmoud, Manal Mohamed
The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study
title The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study
title_full The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study
title_fullStr The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study
title_full_unstemmed The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study
title_short The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study
title_sort role of uca1 and wrap53 in diagnosis of hepatocellular carcinoma: a single-center case-control study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369654/
https://www.ncbi.nlm.nih.gov/pubmed/37502440
http://dx.doi.org/10.5114/ceh.2023.127569
work_keys_str_mv AT abdelmoetyamraly theroleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT elhassafymohamedyoussef theroleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT saidrashasaidomar theroleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT elsheaitaahmed theroleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT mahmoudmanalmohamed theroleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT abdelmoetyamraly roleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT elhassafymohamedyoussef roleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT saidrashasaidomar roleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT elsheaitaahmed roleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy
AT mahmoudmanalmohamed roleofuca1andwrap53indiagnosisofhepatocellularcarcinomaasinglecentercasecontrolstudy